title: Cardiology patient page. Warfarin versus novel oral anticoagulants: how to choose?
authors.affiliation: From the Cardiovascular Division (G.P.) and Department of Medicine (R.K.W., C.E.R.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Rishi K
authors.initials: RK
authors.lastname: Wadhera
authors.affiliation: From the Cardiovascular Division (G.P.) and Department of Medicine (R.K.W., C.E.R.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Cori E
authors.initials: CE
authors.lastname: Russell
authors.affiliation: From the Cardiovascular Division (G.P.) and Department of Medicine (R.K.W., C.E.R.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA. gpiazza@partners.org.
authors.forename: Gregory
authors.initials: G
authors.lastname: Piazza
mesh_terms: D006801:Humans; D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000097:blood; D002318:Cardiovascular Diseases / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy; D002755:Choice Behavior; D014859:Warfarin / Q000008:administration & dosage / Q000097:blood
chemical_list: D000925:Anticoagulants; D014859:Warfarin